Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Cash from Operations: 2010-2019

Historic Cash from Operations for EyePoint Pharmaceuticals (EYPT) over the last 8 years, with Dec 2019 value amounting to -$20.8 million.

  • EyePoint Pharmaceuticals' Cash from Operations fell 25753.09% to -$20.8 million in Q4 2019 from the same period last year, while for Dec 2019 it was -$45.8 million, marking a year-over-year decrease of 67.12%. This contributed to the annual value of -$126.2 million for FY2024, which is 6832.05% down from last year.
  • Latest data reveals that EyePoint Pharmaceuticals reported Cash from Operations of -$20.8 million as of Q4 2019, which was down 55.83% from -$13.3 million recorded in Q1 2019.
  • EyePoint Pharmaceuticals' Cash from Operations' 5-year high stood at $81,000 during Q4 2018, with a 5-year trough of -$20.8 million in Q4 2019.
  • Moreover, its 3-year median value for Cash from Operations was -$5.5 million (2017), whereas its average is -$8.2 million.
  • Its Cash from Operations has fluctuated over the past 5 years, first spiked by 101.61% in 2018, then slumped by 25,753.09% in 2019.
  • Over the past 5 years, EyePoint Pharmaceuticals' Cash from Operations (Quarterly) stood at -$3.2 million in 2015, then tumbled by 57.81% to -$5.0 million in 2016, then decreased by 0.58% to -$5.0 million in 2017, then spiked by 101.61% to $81,000 in 2018, then slumped by 25,753.09% to -$20.8 million in 2019.
  • Its Cash from Operations was -$20.8 million in Q4 2019, compared to -$13.3 million in Q1 2019 and $81,000 in Q4 2018.